The purpose of this study is to determine the safety and effectiveness of combination therapy with Proleukin and Rituxan on patients with low-grade Non-Hodgkin's Lymphoma who have previously failed Rituxan treatments.
Diagnosis and disease status:
Exclusion:
Miami, Florida 33136, United States
New York, New York 10021, United States
Greenville, North Carolina 27858-4354, United States
Columbus, Ohio 43210, United States